Lakewood-Amedex Biotherapeutics Inc. (LABT) Income Statement

21 Followers

Lakewood-Amedex Biotherapeutics Inc. Income Statement

Last quarter (Q2 2026), Lakewood-Amedex Biotherapeutics Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Lakewood-Amedex Biotherapeutics Inc.'s net income was $-3.77M. See Lakewood-Amedex Biotherapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 3.77M
Depreciation and Amortization	$ 119.98K
EBITDA	$ -3.63M
Operating Income	$ -3.77M
Other Income/Expenses	$ -75.27K
Pretax Income	$ -3.85M
Net Income	$ -3.85M
Per Share Metrics
Basic EPS	$ -2.76
Diluted EPS	$ -2.76
Weighted Average Shares Outstanding	1.39M
Weighted Average Shares Outstanding (Diluted)	1.39M

Currency in USD

Lakewood-Amedex Biotherapeutics Inc. (LABT) Income Statement

Lakewood-Amedex Biotherapeutics Inc. Income Statement

Lakewood-Amedex Biotherapeutics Inc. Earnings and Revenue History